Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/19/2848504/0/en/VYNE-Therapeutics-to-Participate-in-the-H-C-Wainwright-2nd-Annual-Autoimmune-Inflammatory-Disease-Virtual-Conference.html
https://www.globenewswire.com//news-release/2024/02/29/2837916/0/en/VYNE-Reports-2023-Fourth-Quarter-and-Year-End-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/21/2832694/0/en/VYNE-Therapeutics-to-Participate-in-the-TD-Cowen-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/01/10/2807052/0/en/VYNE-Therapeutics-Announces-Positive-Biomarker-Data-from-Successful-Phase-1b-Trial-of-VYN201-for-the-Treatment-of-Vitiligo.html
https://www.globenewswire.com//news-release/2024/01/03/2803242/0/en/VYNE-Therapeutics-Appoints-Christine-Borowski-Ph-D-to-its-Board-of-Directors.html
https://www.globenewswire.com//news-release/2023/11/13/2778962/0/en/VYNE-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2023/11/07/2775064/0/en/VYNE-Therapeutics-to-Host-Virtual-R-D-Day-Event-on-November-9-2023.html
https://www.globenewswire.com//news-release/2023/11/01/2771744/0/en/VYNE-Therapeutics-Announces-Closing-of-Previously-Announced-Private-Placement-of-88-2-Million.html
https://www.globenewswire.com//news-release/2023/10/30/2769061/0/en/VYNE-Therapeutics-Reports-Positive-Results-from-Preclinical-Models-for-Oral-BD2-Selective-BET-Inhibitor-VYN202.html
https://www.globenewswire.com//news-release/2023/10/30/2769049/0/en/VYNE-Therapeutics-Announces-Private-Placement-of-88-Million.html